Carter Bankshares (CARE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The 2025 Annual Meeting will be held on May 28, 2025, to elect 11 directors, approve executive compensation, and ratify Crowe LLP as independent auditors.
Shareholders of record as of April 4, 2025, are entitled to vote in person or by proxy, with options to vote online, by phone, or by mail.
The Board recommends voting for all director nominees, for the advisory say-on-pay proposal, and for auditor ratification.
Voting matters and shareholder proposals
Shareholders will vote on electing 11 directors, approving executive compensation (advisory), and ratifying Crowe LLP as auditors for 2025.
Shareholder proposals for the 2026 meeting must be submitted between January 28 and February 27, 2026.
Proxy voting is available online, by phone, or by mail, and proxies may be revoked before the meeting.
Board of directors and corporate governance
The Board will decrease from 12 to 11 members after the 2025 meeting; all nominees are current directors with diverse backgrounds in finance, law, technology, and banking.
Majority of directors are independent; Board committees include Audit, Nominating & Compensation, Credit Risk, Investment/Interest Rate Risk, and Enterprise Risk Management.
Board leadership is separated between the Chairman (not independent) and CEO, with a Lead Independent Director appointed.
Board diversity: 25% female, average independent director age is 65, average tenure is 8 years.
Latest events from Carter Bankshares
- Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 20255 Feb 2026 - Loan and net interest income growth offset by asset quality pressures from a large nonaccrual loan.CARE
Q3 202521 Nov 2025 - Earnings rose on higher net interest income and loan growth, with strong capital and liquidity.CARE
Q2 20254 Aug 2025 - Q3 net income increased, margins improved, and major litigation was resolved.CARE
Q3 202413 Jun 2025 - Net income fell as a large NPL persisted, but capital and liquidity remain strong.CARE
Q2 202413 Jun 2025 - Q1 2025 net income surged 55% year-over-year, with strong capital and loan growth.CARE
Q1 20256 Jun 2025 - Q4 net income up, asset quality improved, but large nonperforming loan still weighs on results.CARE
Q4 20245 Jun 2025